Equities
Health CareMedical Equipment and Services
  • Price (SEK)194.30
  • Today's Change3.45 / 1.81%
  • Shares traded1.02m
  • 1 Year change-7.12%
  • Beta0.6074
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Getinge AB had net income fall -3.17% from 2.49bn to 2.41bn despite a 12.49% increase in revenues from 28.29bn to 31.83bn. An increase in the cost of goods sold as a percentage of sales from 52.60% to 54.46% was a component in the falling net income despite rising revenues.
Gross margin45.80%
Net profit margin5.07%
Operating margin8.65%
Return on assets3.01%
Return on equity5.46%
Return on investment4.00%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Getinge AB fell by 2.95bn. However, the company earned 2.96bn from its operations for a Cash Flow Margin of 9.29%. In addition the company generated 511.00m cash from financing while 6.54bn was spent on investing.
Cash flow per share13.50
Price/Cash flow per share13.43
Book value per share111.09
Tangible book value per share-24.10
More ▼

Balance sheet in SEKView more

Getinge AB has a Debt to Total Capital ratio of 26.29%, a higher figure than the previous year's 14.30%.
Current ratio1.07
Quick ratio0.5965
Total debt/total equity0.3592
Total debt/total capital0.2629
More ▼

Growth rates in SEK

Year on year, growth in dividends per share increased 3.53% while earnings per share excluding extraordinary items fell by -3.17%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized dividend per share growth ranks highest in its industry.
Div yield(5 year avg)1.43%
Div growth rate (5 year)34.49%
Payout ratio (TTM)70.85%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-24.84
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.